Issue
Korean Journal of Chemical Engineering,
Vol.40, No.2, 390-397, 2023
Cryopreservable three-dimensional spheroid culture for ready-to-use systems
Three-dimensional (3D) spheroid culture has applications in many fields as spheroids closely recapitulate physiological conditions. However, spheroid culture and maintenance are time-consuming and unsuitable for urgent situations; therefore, appropriate cryopreservation methods for spheroids are required for their use in an on-demand and ready-to-use manner. We hypothesized that the feasibility of a ready-to-use system relies on diffusion of the preservation solution within spheroids; we thus evaluated the effects of spheroid-forming parameters, such as cell number and culture period, on spheroid viability and functionality. Long-term spheroid culture for seven days interfered with penetration of the cryopreservation solution as it caused cell condensation and extracellular matrix (ECM) secretion, as well as low viability and migratory activity upon replating after storage. However, ready-to-use spheroids, which were cultured for one day and then cryopreserved, showed viability and migration similar to those of non-cryopreserved spheroids, confirming that a short incubation period was suitable for this system. The chondrocyte-based ready-to-use spheroid system designed in this study can be easily applied to regenerative medicine applications that require a large number of cells in the future and can provide information for applying the ready-to-use spheroid system to various cell types.
[References]
  1. Chaicharoenaudomrung N, Kunhorm P, Noisa P, World J. Stem Cells, 11, 1065, 2019
  2. Kang SW, Park JHO, Kim BS, J. Microbiol. Biotechnol., 15, 259, 2005
  3. Cho MO, Li Z, Shim HE, Cho IS, Nurunnabi M, Park H, Lee KY, Moon SH, Kim KS, Kang SW, Huh KM, NPG Asia Mater., 8, e309, 2016
  4. Moon SH, Kang SW, Park SJ, Bae D, Kim SJ, Lee HA, Kim KS, Hong KS, Kim JS, Do JT, Byun KH, Chung HM, Biomaterials, 34, 4013, 2013
  5. Kim W, Gwon Y, Park S, Kim H, Kim J, Bioact Mater, 19, 50, 2022
  6. Kim DE, Lee YB, Shim HE, Song JJ, Han JS, Moon KS, Huh KM, Kang SW, ACS Omega, 7, 18471, 2022
  7. Wang A, Madden LA, Paunov VN, J. Mater. Chem. B, 8, 10487, 2020
  8. Meneghel J, Kilbride P, Morris GJ, Front Med, 7, 592242, 2020
  9. Park Y, Huh KM, Kang SW, Int. J. Mol. Sci., 22, 2491, 2021
  10. Dong H, Li X, Chen K, Li N, Kagami H, Tissue Eng. Part C Methods, 27, 253, 2021
  11. Arai K, Murata D, Takao S, Verissiomo AR, Nakayama K, PLoS One, 15, e0230428, 2020
  12. Hunt CJ, Transfusion Med. Hemother., 46, 134, 2019
  13. Chang T, Zhao G, Adv. Sci., 8, 2002425, 2021
  14. Liu Y, Shah KM, Luo J, Front. Bioeng. Biotechnol., 9, 770655, 2021
  15. Lv Z, Li J, Xu X, Jiang Q, Shi D, Ann. Joint, 5, 33, 2020
  16. Lee JI, Sato M, Kim HW, Mochida J, Eur. Cell Mater, 22, 275, 2011
  17. Schulze-Tanzil G, Ann. Anat, 191, 325, 2009
  18. Jeon JH, Yun BG, Lim MJ, Kim SJ, Lim MH, Lim JY, Park SH, Kim SW, Tissue Eng. Regen Med., 17, 81, 2020
  19. Kang SW, Yoo SP, Kim BS, Biomed Mater. Eng., 17, 269, 2007
  20. Yhee JY, Kim YJ, Ryu JH, Yoon HY, Chang H, Park JH, Lee H, Jang HS, Jeong U, Kim K, Kang SW, Macromol. Biosci., 15, 1224, 2015
  21. Takahashi T, Ogasawara T, Asawa Y, Mori Y, Uchinuma E, Takato T, Hoshi K, Tissue Eng., 13, 1583, 2007
  22. Edmondson R, Broglie JJ, Adcock AF, Yang L, Assay Drug Dev. Technol., 12, 207, 2014
  23. Lin Z, Willers C, Xu J, Zheng MH, Tissue Eng., 12, 1971, 2006
  24. Jang TH, Park SC, Yang JH, Kim JY, Seok JH, Park US, Choi CW, Lee SR, Han J, Integr. Med. Res., 6, 12, 2017
  25. Pinto B, Henriques AC, Silva PMA, Bousbaa H, Pharmaceutics, 12, 1186, 2020
  26. Thakuri PS, Gupta M, Plaster M, Tavana H, Assay Drug Dev. Technol., 17, 140, 2019
  27. Ryu NE, Lee SH, Park H, Cells, 8, 1620, 2019
  28. Lee NH, Bayaraa O, Zechu Z, Kim HS, BMB Rep., 54, 356, 2021